Zhejiang Medicine (600216.SH) has announced a forecasted increase, expecting a net profit of 1.039-1.246 billion yuan in 2024, an increase of 141.83%-190.01% compared to the previous year.
Zhejiang Medicine (600216.SH) has issued an announcement, the company is expected to achieve a net profit attributable to the parent company in the year of 2024...
Zhejiang Medicine (600216.SH) issued an announcement, stating that the company is expected to achieve a net profit attributable to the owners of the parent company of 1.039 billion to 1.246 billion yuan in 2024. Compared with the same period last year, it will increase by 609.36 million to 816.36 million yuan, a year-on-year increase of 141.83% to 190.01%.
Related Articles
IVD MEDICAL intends to change its name to ETHK Labs! "Chain" moves the world ETHK strategic opening of the asset "chain out to sea" era
YEE HOP HLDGS (01662) short suspension of trading starting from September 16th pending the publication of insider information.
"Abandoning medicine for chains" Hua Jian (01931) - Will ETHK become the next wealth-making myth or a vegetable harvesting machine?
IVD MEDICAL intends to change its name to ETHK Labs! "Chain" moves the world ETHK strategic opening of the asset "chain out to sea" era
YEE HOP HLDGS (01662) short suspension of trading starting from September 16th pending the publication of insider information.
"Abandoning medicine for chains" Hua Jian (01931) - Will ETHK become the next wealth-making myth or a vegetable harvesting machine?
